Delivery Order SPE2DB24D9802-SPE2DB25FJKYH

Award Date 6/9/25
Potential Completion Date 6/10/25
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,374.65, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of Jardiance 10 mg tablets, a prescription medication. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through...
This federal contract award, valued at $10,775.98, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is a firm fixed-price delivery order for the supply of JARDIANCE 10 MG TABLET 90S, with a completion date of February 8, 2023. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through...
This federal contract award was issued by the Defense Logistics Agency (DLA) under its Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,047.32 firm fixed-price delivery order is for the supply of Jardiance 10 mg tablets to support the recurring medical needs of military health facilities. The award is made under DMS Pharmaceutical Group's existing $499,999,999 indefinite delivery contract with the DLA, which allows the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,275.40 contract is for the delivery of 90 tablets of Jardiance 10 mg, a prescription medication. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which provides a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,047.32 firm fixed-price contract is for the delivery of Jardiance 10 mg tablets to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, that runs through...
This federal contract award, valued at $2,047.32, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a delivery order under DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, contract 4600082013 under the SPE2DB program, which has a ceiling value of up to $4,999,999 through 2025. The specific product being delivered under this award is JARDIANCE 25 MG TABLET 90S....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of Jardiance 10 mg tablets. The contract has a potential value of $2,047.32 and a completion date of February 9, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that offers a comprehensive range of brand and generic prescription and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $9,432.80 contract is for the delivery of the pharmaceutical product Jardiance 10 mg tablets with a completion date of June 9, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm fixed-price delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Jardiance 10 mg tablets. The contract has a potential value of $2,047.32 and a completion date of February 9, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds a broader Indefinite Delivery Vehicle (IDV) contract, SPE2DB, with the Defense Logistics Agency valued at...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The $8,530.50 award covers the supply of 90-count bottles of the medication Jardiance 10 mg tablets. The order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which provides a wide range of pharmaceutical products and medical...
  • SPE2DB24D9802
    Indefinite Delivery Contract
  • SPE2DB24D9802-SPE2DB25FJKYH
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $20,088.00 firm fixed-price delivery order is for 90 tablets of the drug Jardiance 10 mg, with a completion date of June 10, 2025.

DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables.

The contract was not set aside for any specific socioeconomic program. DMS Pharmaceutical Group's status as a woman-owned small business has allowed the company to compete effectively for federal pharmaceutical contracts without requiring set-aside designations.

Generated 9/14/25, 12:59 AM